Abbott Laboratories remains a “Buy,” anticipating double-digit growth, despite near-term volatility and underwhelming 2026 guidance. Click for more on ABT.
Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least
Latest from Blog
Wachtell Guides Abbott Nutrition Spinoff Into Public Co.
Wachtell Lipton Rosen & Katz guided healthcare company Abbott in a plan to spin off its nutrition business into an independent, publicly traded company anchored by brands such as adult supplement Ensure
Abbott To Spin Off $8.5 Billion Nutrition Business Into Independent Public Company By End Of 2027
Abbott, a global healthcare company, announced plans to separate its Nutrition business into an independent, publicly traded company with approximately $8.5 billion in annual sales. The proposed transaction will establish a standalone
Farm to Early Care and Education and Child and Adult Care Food Program: Growing Healthy Futures – Food Research & Action Center
Published October 21, 2026 October 19–23 is Farm to CACFP (Child and Adult Care Food Program) Week, which highlights the benefits of connecting child and adult care providers with local foods. CACFP,
Smoothie swaps could unlock hidden health benefits
Post Views: 0
Opinion: Abbott’s family tree is growing. Will its newest branch thrive like AbbVie?
The classroom lesson of addition by subtraction is about to be tested again. Post Views: 0